Appleton Partners’s Biogen BIIB Stock Holding History

Appleton Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-910	Closed	-$255K	–	287
2021 Q1	$255K	Sell	910 -104	-10%	-$28K	0.02%	258
2020 Q4	$248K	Buy	+1,014	New	+$262K	0.02%	249
2020 Q2	–	Sell	-833	Closed	-$264K	–	259
2020 Q1	$264K	Sell	833 -150	-15%	-$45.5K	0.04%	225
2019 Q4	$292K	Buy	+983	New	+$273K	0.03%	243
2019 Q2	–	Sell	-948	Closed	-$224K	–	280
2019 Q1	$224K	Hold	948	–	–	0.03%	249
2018 Q4	$285K	Sell	948 -2,447	-72%	-$781K	0.04%	219
2018 Q3	$1.2M	Sell	3,395 -7	-0.2%	-$2.41K	0.16%	129
2018 Q2	$987K	Sell	3,402 -74	-2%	-$20.8K	0.14%	143
2018 Q1	$952K	Buy	3,476 +94	+3%	+$29.2K	0.14%	144
2017 Q4	$1.08M	Buy	3,382 +13	+0.4%	+$4.17K	0.17%	133
2017 Q3	$1.05M	Sell	3,369 -2,355	-41%	-$697K	0.18%	128
2017 Q2	$1.55M	Buy	5,724 +2,334	+69%	+$617K	0.26%	95
2017 Q1	$927K	Sell	3,390 -2,484	-42%	-$702K	0.17%	124
2016 Q4	$1.67M	Sell	5,874 -210	-3%	-$62.2K	0.34%	81
2016 Q3	$1.9M	Buy	6,084 +2,112	+53%	+$626K	0.36%	76
2016 Q2	$961K	Sell	3,972 -321	-7%	-$84.6K	0.2%	104
2016 Q1	$1.12M	Sell	4,293 -311	-7%	-$82.2K	0.22%	91
2015 Q4	$1.41M	Buy	4,604 +523	+13%	+$150K	0.28%	82
2015 Q3	$1.19M	Sell	4,081 -5,416	-57%	-$1.79M	0.27%	86
2015 Q2	$3.84M	Buy	9,497 +226	+2%	+$90.7K	0.86%	43
2015 Q1	$3.92M	Buy	+9,271	New	+$3.65M	0.88%	41
2014 Q2	–	Sell	-771	Closed	-$236K	–	177
2014 Q1	$236K	Buy	+771	New	+$245K	0.06%	162

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Appleton Partners's BIIB Position: Q2 2021 in Review

Appleton Partners sold out of Biogen (BIIB) in Q2 2021, closing a stake of 910 shares — an estimated $255K sold.

Appleton Partners first reported a position in BIIB in Q1 2014 and held it in 22 quarters. The position peaked at $3.92M in Q1 2015. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Appleton Partners reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Appleton Partners sold 910 Biogen shares in Q2 2021, an estimated $255K.
Appleton Partners first reported a position in Biogen in Q1 2014 and held it in 22 quarters.
Appleton Partners's Biogen position peaked at $3.92M in Q1 2015.
1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Appleton Partners's 13F filing for Q2 2021, filed 7 Jul 2021.